Discovery of synergistic drug combinations for E. coli from drug information, pathogen response and disease microenvironment data

Authors

Institutions

Publication Details

Journal
BMC Artificial Intelligence
Published
2026-03-02
DOI
https://doi.org/10.1186/s44398-026-00023-y
Primary Topic
Escherichia coli research studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of synergistic drug combinations for E. coli from drug information, pathogen response and disease microenvironment data

Fredrick Elishama Kakembo, Ronald Galiwango, Andrew Walakira, Patricia Nabisubi et al.
BMC Artificial Intelligence
Escherichia coli research studies
article

Discovery of synergistic drug combinations for E. coli from drug information, pathogen response and disease microenvironment data

Fredrick Elishama Kakembo, Ronald Galiwango, Andrew Walakira, Patricia Nabisubi, Kevin Cissy Nabukeera, Gloria Loyce Nankoma, Moses Ainembabazi, Racheal Claire Kyomukama
article en

Abstract

No abstract available for this paper.
BMC Artificial IntelligenceVol. 2(1)
Infectious Diseases Institute (UG), Makerere University (UG)
Wellcome Trust, Universidade Federal Rural da Amazônia, National Institutes of Health, University of California, San Francisco
Openalex Percentile: Top 33%
Escherichia coli research studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.